Clinical Trials Insight: 700014389
Phase of Trial: Phase II
Latest Information Update: 22 Dec 2006
At a glance
- Drugs Peptide YY 3-36; Peptide YY 3-36
- Indications Obesity
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Marina Biotech
- 22 Dec 2006 Status changed from in progress to completed
- 17 Aug 2006 The expected completion date for this trial is now 1 Sep 2006.
- 17 Aug 2006 New trial record.